Skip to content

DRD

Active
Private limited companyfounded 2015active for 11 yearsGentsesteenweg 101, 9900 Eeklo, BelgiumKBO/BCE: BE 0628.740.637

From the official registers: KBO 4 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

DRD has been active since 2015 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €70,477 and a net result of €32,527. Equity is growing by about 125% per year across the filed financial years. Its solvency ranks better than 53% of 615 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Financials · financial year 2025, micro format

Latest annual accounts filed

Annual accounts 2025

View at the NBB
Financial year ended
31-12-2025
Filed on
08-07-2026
Format
micro format
Reference
2026-00275175
Turnover
≈ €200,000
Estimated: probably between €120,000 and €350,000
Total assets
€110,343▼ 26.9%
2024 · €150,992
Net result
€32,527▲ 4.8%
2024 · €31,049
Working capital
€17,781
2024 · -€12,460
Trend over the years

2022 to 2025, 4 financial years

The operating result has risen three years in a row; 2025 is 13% above 2024 and is the highest result in the available series.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€46,822 2025 Net result€32,527 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 72, Scientific research and development: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line2022202320242025
Operating result-€3,497-€12,256€41,433▲ 238%€46,822▲ 13.0%
Net result-€3,632below the sector's middle half-€11,450within the sector's middle half€31,049within the sector's middle half▲ 171%€32,527within the sector's middle half▲ 4.8%
Equity-€4,549below the sector's middle half-€6,901below the sector's middle half€37,950within the sector's middle half▲ 450%€70,477within the sector's middle half▲ 85.7%
Total assets€9,014below the sector's middle half-€62,080below the sector's middle half▲ 589%€150,992within the sector's middle half▲ 143%€110,343within the sector's middle half▼ 26.9%
Debt€13,563-€55,179▲ 307%€113,042▲ 105%€39,867▼ 64.7%
Working capital-€5,107below the sector's middle half--€44,509below the sector's middle half▼ 772%-€12,460below the sector's middle half▲ 72.0%€17,781within the sector's middle half
Solvency-50.5%below the sector's middle half-11.1%below the sector's middle half▲ 61.6pp25.1%below the sector's middle half▲ 14.0pp63.9%within the sector's middle half▲ 38.7pp
Current ratio0.62below the sector's middle half-0.19below the sector's middle half▼ 0.430.89below the sector's middle half▲ 0.701.47within the sector's middle half▲ 0.58
Return on assets (ROA)-40.3%below the sector's middle half-18.4%within the sector's middle half▲ 58.7pp20.6%within the sector's middle half▲ 2.1pp29.5%above the sector's middle half▲ 8.9pp
above within below the middle half of NACE 72, Scientific research and development: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the micro format does not require them. The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €110,343
Fixed assets €55,010 ▲ 9.1%
Current assets €55,333 ▼ 45.0%
Equity and liabilities €110,343
Equity €70,477 ▲ 85.7%
Debt €39,867 ▼ 64.7%
Debt's share of the balance-sheet total falls from 74.9% to 36.1%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€48,022▲
2024 · €42,433
Cash flow
€33,727▲
2024 · €32,049
Debt to equity
0.57▼
2024 · 2.98
ROE
46.2%▼
2024 · 81.8%
Interest coverage
14.07▼
2024 · over 100
Debt ≤ 1 year
€37,552▼
2024 · €113,042
Income taxes
€10,882▲
2024 · €10,350
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 34,693 companies that looked in July 2024 the way this one looks now, 0.7% went bankrupt within 24 months and 95.3% are still going.

  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.7% went bankrupt
3.9% stopped otherwise
95.3% still going

For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 34,693 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 46 lines

Source: Annual accounts 2025 at the NBB, filed with the National Bank on 08-07-2026.

Balance sheet Code20242025
Assets
Total assets20/58€150,992€110,343▼
Fixed assets21/28€50,410€55,010▲
Intangible fixed assets21-€2,797
Tangible fixed assets22/27€3,068€4,871▲
Plant, machinery and equipment23€62€2,617▲
Furniture and vehicles24€3,006€2,254▼
Financial fixed assets28€47,342€47,342=
Current assets29/58€100,582€55,333▼
Amounts receivable within one year40/41€5,167€8,652▲
Trade receivables40€517€438▼
Other amounts receivable41€4,650€8,214▲
Cash at bank and in hand54/58€95,415€39,833▼
Deferred charges and accrued income490/1-€6,849
Equity and liabilities
Total equity and liabilities10/49€150,992€110,343▼
Equity10/15€37,950€70,477▲
Contributions10/11€600€600=
Reserves13€37,000€69,000▲
Tax-exempt reserves132€1,977€1,949▼
Distributable reserves133€35,023€67,051▲
Profit (loss) carried forward14€350€877▲
Amounts payable17/49€113,042€39,867▼
Amounts payable within one year42/48€113,042€37,552▼
Trade debts44€49,993€5,451▼
Suppliers440/4€49,993€5,451▼
Taxes, remuneration and social security45€13,671-
Taxes450/3€13,671-
Other amounts payable47/48€49,378€32,101▼
Accrued charges and deferred income492/3-€2,315
Income statement Code20242025
Non-recurring operating income76A€20,000-
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1,000€1,200▲
Other operating charges640/8€809€825▲
Gross operating margin9900€43,242€48,847▲
Operating profit (loss)9901€41,433€46,822▲
Financial income75/76B€68€0▼
Recurring financial income75€68€0▼
Financial charges65/66B€103€3,413▲
Recurring financial charges65€103€3,413▲
Profit (loss) for the period before taxes9903€41,399€43,409▲
Income taxes67/77€10,350€10,882▲
Profit (loss) for the period9904€31,049€32,527▲
Transfer from tax-exempt reserves789-€29
Profit (loss) for the period to be appropriated9905€31,049€32,556▲
Appropriation of the result
Profit (loss) to be appropriated9906€31,350€32,905▲
Profit (loss) brought forward from the previous period14P€301€350▲
Transfer to equity691/2€31,000€32,029▲
To other reserves6921€31,000€32,029▲

The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are in the accounts filed with the National Bank.

Line2022202320242025Change
Non-recurring operating income76A--€20,000--
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€248€250€1,000€1,200▲ 20.0%
Other operating charges640/8€900€797€809€825▲ 2.0%
Gross operating margin9900-€2,349€13,303€43,242€48,847▲ 13.0%
Operating profit (loss)9901-€3,497€12,256€41,433€46,822▲ 13.0%
Financial income75/76B€1€0€68€0▼ 99.9%
Recurring financial income75€1€0€68€0▼ 99.9%
Financial charges65/66B€136€614€103€3,413▲ 33×
Recurring financial charges65€136€614€103€3,413▲ 33×
Profit (loss) for the period before taxes9903-€3,632€11,642€41,399€43,409▲ 4.9%
Income taxes67/77-€193€10,350€10,882▲ 5.1%
Profit (loss) for the period9904-€3,632€11,450€31,049€32,527▲ 4.8%
Transfer from tax-exempt reserves789---€29-
Transfer to tax-exempt reserves689-€1,977---
Profit (loss) for the period to be appropriated9905-€3,632€9,472€31,049€32,556▲ 4.9%
Line2022202320242025Change
Assets
Total assets20/58€9,014€62,080€150,992€110,343▼ 26.9%
Fixed assets21/28€558€51,410€50,410€55,010▲ 9.1%
Intangible fixed assets21---€2,797-
Tangible fixed assets22/27€558€4,068€3,068€4,871▲ 58.8%
Plant, machinery and equipment23€558€310€62€2,617▲ 42×
Furniture and vehicles24-€3,758€3,006€2,254▼ 25.0%
Financial fixed assets28-€47,342€47,342€47,342=
Current assets29/58€8,456€10,670€100,582€55,333▼ 45.0%
Amounts receivable within one year40/41€3,223€1,357€5,167€8,652▲ 67.4%
Trade receivables40€3,223€1,050€517€438▼ 15.3%
Other amounts receivable41-€307€4,650€8,214▲ 76.6%
Cash at bank and in hand54/58€5,233€9,313€95,415€39,833▼ 58.3%
Deferred charges and accrued income490/1---€6,849-
Equity and liabilities
Total equity and liabilities10/49€9,014€62,080€150,992€110,343▼ 26.9%
Equity10/15-€4,549€6,901€37,950€70,477▲ 85.7%
Contributions10/11€600€600€600€600=
Reserves13-€6,000€37,000€69,000▲ 86.5%
Tax-exempt reserves132-€1,977€1,977€1,949▼ 1.4%
Distributable reserves133-€4,023€35,023€67,051▲ 91.5%
Profit (loss) carried forward14-€5,149€301€350€877▲ 151%
Amounts payable17/49€13,563€55,179€113,042€39,867▼ 64.7%
Amounts payable within one year42/48€13,563€55,179€113,042€37,552▼ 66.8%
Trade debts44€9,400€5,428€49,993€5,451▼ 89.1%
Suppliers440/4€9,400€5,428€49,993€5,451▼ 89.1%
Taxes, remuneration and social security45€2,036€374€13,671--
Taxes450/3€2,036€374€13,671--
Other amounts payable47/48€2,127€49,378€49,378€32,101▼ 35.0%
Accrued charges and deferred income492/3---€2,315-
Line2022202320242025Change
Profit (loss) for the period9904-€3,632€11,450€31,049€32,527▲ 4.8%
+ Depreciation and write-downs630€248€250€1,000€1,200▲ 20.0%
Operating cash flow (approximation)-€3,384€11,700€32,049€33,727▲ 5.2%
Investment in fixed assets (approximation)--€51,102€0-€5,800-
Change in cash-€4,080€86,102-€55,581-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (4)
Financial year Type Filed Reference Document
31-12-2025 micro format 08-07-2026 2026-00275175 NBB
31-12-2024 micro format 25-07-2025 2025-00317417 PDF
31-12-2023 micro format 22-07-2024 2024-00277594 PDF
31-12-2022 micro format 17-07-2023 2023-00251035 PDF

Similar companies · same sector, comparable size

Of the 760 active companies whose main activity is research and development on biotechnology (NACE 72101), figures are known for 484. 267 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.